Related Experiment Video
Updated: Jun 13, 2026

11:22
Vibratome Sectioning Mouse Retina to Prepare Photoreceptor Cultures
Published on: December 22, 2014
Downregulating Nrl Expression and Rod Photoreceptor Protection
Yiwen Li1, Shuliang Jiao2, Weng Tao3
1Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
International Journal of Molecular Sciences
|June 12, 2026
Summary
Downregulating neural retina leucine zipper (Nrl) reprograms rod photoreceptors, making them more resistant to degeneration. This approach shows promise as a broad, mutation-independent therapy for retinitis pigmentosa.
Area of Science:
- Genetics and Molecular Biology
- Ophthalmology
- Cellular Biology
Background:
- Retinitis pigmentosa (RP) is an inherited retinal degeneration causing progressive vision loss.
- RP primarily affects rod photoreceptors, leading to secondary cone cell loss.
- The neural retina leucine zipper (Nrl) transcription factor is crucial for rod photoreceptor development.
Purpose of the Study:
- To investigate if downregulating Nrl can reprogram rod photoreceptors into a more resilient state.
- To assess the therapeutic potential of Nrl downregulation in preclinical models of RP.
Main Methods:
- Generated transgenic mice with downregulated Nrl (NrlN/N).
- Crossed NrlN/N mice with established RP models (rd1 and RhoP23H/P23H).
- Utilized adeno-associated virus (AAV)-mediated shRNA delivery to knockdown Nrl in rd10 mice.
Main Results:
- Downregulation of Nrl shifted rod phenotype towards a precursor-like state, especially in the inferior retina.
- Double-mutant mice (NrlN/N with rd1 or RhoP23H/P23H) exhibited significantly improved photoreceptor survival.
- AAV-mediated Nrl knockdown in rd10 mice substantially enhanced photoreceptor survival.
Conclusions:
- Downregulation of Nrl confers broad resistance to photoreceptor degeneration across various RP models.
- AAV-mediated Nrl knockdown is a promising mutation-independent therapeutic strategy for both autosomal recessive and dominant RP.
- This approach offers potential for treating a wide spectrum of retinitis pigmentosa patients.

